ClinConnect ClinConnect Logo
Search / Trial NCT05748314

Marfan Syndrome and Quality of Life of Pediatric Patients

Launched by IRCCS POLICLINICO S. DONATO · Feb 24, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Quality Of Life Self Identification Self Care

ClinConnect Summary

This clinical trial is focused on understanding how Marfan syndrome (MFS) affects the quality of life in children and teenagers. Researchers want to find out how MFS impacts things like self-image, self-management skills, and whether patients need psychological support. To do this, participants will fill out four questionnaires that will help gather information about their experiences living with Marfan syndrome.

If you or your child has been diagnosed with Marfan syndrome and meets certain criteria, you may be eligible to participate in this study. Specifically, participants need to have signed consent and a diagnosis of MFS based on established guidelines. However, if there are known cognitive difficulties, the individual won't be able to join the study. This research is currently looking for participants of all genders, aged up to 74, and aims to provide insights that could improve support and resources for those living with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Signed informed consent;
  • MFS diagnosis according to Revised Ghent criteria (2010);
  • Exclusion Criteria:
  • Known cognitive deficits

About Irccs Policlinico S. Donato

IRCCS Policlinico S. Donato is a leading Italian research hospital and clinical trial sponsor dedicated to advancing medical science through innovative research and patient care. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it is recognized for its commitment to high-quality clinical research and the integration of scientific investigation with clinical practice. The institution specializes in various medical fields, including cardiology, oncology, and neurology, and collaborates with universities and research organizations to facilitate cutting-edge studies. With a focus on improving patient outcomes and contributing to public health, IRCCS Policlinico S. Donato plays a pivotal role in the development of new therapies and treatment protocols.

Locations

San Donato Milanese, Milano, Italy

Patients applied

0 patients applied

Trial Officials

Alessandro Pini, MD

Principal Investigator

Cardiovascular-Gentic Centre, IRCCS Policlinico San Donato

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials